These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 33307944)
21. Novel Nano-Therapeutic Approach Actively Targets Human Ovarian Cancer Stem Cells after Xenograft into Nude Mice. Abou-ElNaga A; Mutawa G; El-Sherbiny IM; Abd-ElGhaffar H; Allam AA; Ajarem J; Mousa SA Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417924 [TBL] [Abstract][Full Text] [Related]
22. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles. Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432 [TBL] [Abstract][Full Text] [Related]
23. Development of Nanoparticles for Drug Delivery to Brain Tumor: The Effect of Surface Materials on Penetration Into Brain Tissue. Lei C; Davoodi P; Zhan W; Chow PK; Wang CH J Pharm Sci; 2019 May; 108(5):1736-1745. PubMed ID: 30552956 [TBL] [Abstract][Full Text] [Related]
24. The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells. Xu Y; Shen M; Li Y; Sun Y; Teng Y; Wang Y; Duan Y Oncotarget; 2016 Apr; 7(15):20890-901. PubMed ID: 26956046 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line. Jamali Z; Khoobi M; Hejazi SM; Eivazi N; Abdolahpour S; Imanparast F; Moradi-Sardareh H; Paknejad M Photodiagnosis Photodyn Ther; 2018 Sep; 23():190-201. PubMed ID: 29969678 [TBL] [Abstract][Full Text] [Related]
26. Preparation of size-tunable sub-200 nm PLGA-based nanoparticles with a wide size range using a microfluidic platform. Bao Y; Maeki M; Ishida A; Tani H; Tokeshi M PLoS One; 2022; 17(8):e0271050. PubMed ID: 35925917 [TBL] [Abstract][Full Text] [Related]
27. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response. Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314 [TBL] [Abstract][Full Text] [Related]
28. Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. Fonseca C; Simões S; Gaspar R J Control Release; 2002 Oct; 83(2):273-286. PubMed ID: 12363453 [TBL] [Abstract][Full Text] [Related]
29. Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles. Gullotti E; Park J; Yeo Y Pharm Res; 2013 Aug; 30(8):1956-67. PubMed ID: 23609560 [TBL] [Abstract][Full Text] [Related]
30. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524 [TBL] [Abstract][Full Text] [Related]
31. Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation Ma P; Huang J; Liu J; Zhu Y; Chen J; Chen J; Lei L; Guan Z; Ban J; Lu Z J Cancer; 2023; 14(5):759-769. PubMed ID: 37056390 [No Abstract] [Full Text] [Related]
32. Vitamin E-Oligo(methyl diglycol l-glutamate) as a Biocompatible and Functional Surfactant for Facile Preparation of Active Tumor-Targeting PLGA Nanoparticles. Wu J; Zhang J; Deng C; Meng F; Zhong Z Biomacromolecules; 2016 Jul; 17(7):2367-74. PubMed ID: 27305935 [TBL] [Abstract][Full Text] [Related]
33. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells. Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410 [TBL] [Abstract][Full Text] [Related]
34. Preparation and In Vitro/Vivo Evaluation of Folate-conjugated Pluronic F87-PLGA/TPGS Mixed Nanoparticles for Targeted Drug Delivery. Wu T; Gong Y; Li Z; Li Y; Xiong X Curr Drug Deliv; 2021; 18(10):1505-1514. PubMed ID: 33845742 [TBL] [Abstract][Full Text] [Related]
35. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles. Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226 [TBL] [Abstract][Full Text] [Related]
36. Targeted delivery of nano-PTX to the brain tumor-associated macrophages. Zou L; Tao Y; Payne G; Do L; Thomas T; Rodriguez J; Dou H Oncotarget; 2017 Jan; 8(4):6564-6578. PubMed ID: 28036254 [TBL] [Abstract][Full Text] [Related]
37. Preparation and evaluation of paclitaxel-loaded reactive oxygen species and glutathione redox-responsive poly(lactic-co-glycolic acid) nanoparticles for controlled release in tumor cells. Wang S; Han F; Xie L; Liu Y; Yang Q; Zhao D; Zhao X Nanomedicine (Lond); 2022 Sep; 17(22):1627-1648. PubMed ID: 36636982 [No Abstract] [Full Text] [Related]
38. A novel technique for loading of paclitaxel-PLGA nanoparticles onto ePTFE vascular grafts. Lim HJ; Nam HY; Lee BH; Kim DJ; Ko JY; Park JS Biotechnol Prog; 2007; 23(3):693-7. PubMed ID: 17465527 [TBL] [Abstract][Full Text] [Related]
39. Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment. Zhong Y; Su T; Shi Q; Feng Y; Tao Z; Huang Q; Li L; Hu L; Li S; Tan H; Liu S; Yang H Int J Nanomedicine; 2019; 14():8543-8560. PubMed ID: 31802868 [TBL] [Abstract][Full Text] [Related]
40. Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma. Ganipineni LP; Ucakar B; Joudiou N; Riva R; Jérôme C; Gallez B; Danhier F; Préat V J Drug Target; 2019; 27(5-6):614-623. PubMed ID: 30633585 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]